NCT01346852
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
Not specified
Clinical trial condition
Lung Diseases, Obstructive
Explore clinical trials studying Lung Diseases, Obstructive. Study availability and eligibility vary by location and protocol.
7,975 public trials
742 recruiting studies
Lung Diseases, Obstructive trial results
NCT01563029
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- GSK Investigational Site Little Rock, Arkansas, United States
- GSK Investigational Site Costa Mesa, California, United States
- GSK Investigational Site Huntington Beach, California, United States
- GSK Investigational Site Long Beach, California, United States
NCT01430403
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- National Jewish Health Denver, Colorado, United States
- Children's National Medical Center Washington D.C., District of Columbia, United States
- Children's Memorial Hospital - Department of Allergy Chicago, Illinois, United States
- Boston University School of Medicine Boston, Massachusetts, United States
- Conditions
- Chronic Disease, Disease Attributes, Lung Diseases, +5 more
- Locations
-
Not specified
NCT03169270
- Conditions
- Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +7 more
- Locations
-
Not specified
NCT02416180
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- GSK Investigational Site Frankfurt am Main, Hesse, Germany
- GSK Investigational Site Frankfurt am Main, Hesse, Germany
- GSK Investigational Site Neu-Isenburg, Hesse, Germany
- GSK Investigational Site Reinfeld, Schleswig-Holstein, Germany
NCT01156701
- Conditions
- Asthma, Bronchial Diseases, Bronchial Spasm, +29 more
- Locations
-
Not specified
NCT00291382
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- GSK Investigational Site Ghent, Belgium
- GSK Investigational Site Liège, Belgium
- GSK Investigational Site Tartu, Estonia
- GSK Investigational Site Jyväskylä, Finland
Completed
Effect of Supplementary Vitamins on Oxidant Gene Expression in the Lungs of Healthy Smokers
NCT00565214
- Conditions
- Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), Disease Attributes, +6 more
- Locations
-
- Weill Cornell Medical College New York, United States
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- GSK Investigational Site Nizhny Novgorod, Russia
- GSK Investigational Site Penza, Russia
- GSK Investigational Site Ryazan, Russia
- GSK Investigational Site Smolensk, Russia